Baird Financial Group
RVNC

Baird Financial Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

Baird Financial Group’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-61,586
Closed -$706K – 1812
2023
Q3 		$706K Buy
61,586
+940
+2% +$18.1K ﹤0.01% 1210
2023
Q2 		$1.53M Sell
60,646
-927
-2% -$28.9K ﹤0.01% 989
2023
Q1 		$1.98M Buy
61,573
+2,013
+3% +$62.8K ﹤0.01% 888
2022
Q4 		$1.1M Buy
59,560
+516
+0.9% +$11.8K ﹤0.01% 1043
2022
Q3 		$1.59M Buy
+59,044
New +$1.2M ﹤0.01% 912
2021
Q4 		– Sell
-48,515
Closed -$1.35M – 1943
2021
Q3 		$1.35M Buy
48,515
+9,488
+24% +$271K ﹤0.01% 1083
2021
Q2 		$1.16M Buy
39,027
+11,760
+43% +$339K ﹤0.01% 1135
2021
Q1 		$762K Buy
+27,267
New +$754K ﹤0.01% 1235
2020
Q4 		– Sell
-19,244
Closed -$484K – 1605
2020
Q3 		$484K Buy
19,244
+3,503
+22% +$91.8K ﹤0.01% 1163
2020
Q2 		$384K Buy
+15,741
New +$311K ﹤0.01% 1216
2016
Q3 		– Sell
-94,308
Closed -$1.28M – 1231
2016
Q2 		$1.28M Sell
94,308
-11,957
-11% -$211K 0.01% 668
2016
Q1 		$1.85M Buy
106,265
+23,655
+29% +$481K 0.02% 552
2015
Q4 		$2.82M Buy
82,610
+13,114
+19% +$455K 0.03% 460
2015
Q3 		$2.07M Buy
69,496
+35,315
+103% +$1.07M 0.02% 504
2015
Q2 		$1.09M Buy
+34,181
New +$879K 0.01% 730

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baird Financial Group's RVNC Position: Q4 2023 in Review

Baird Financial Group sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2023, closing a stake of 61,586 shares — an estimated $706K sold.

Baird Financial Group first reported a position in RVNC in Q2 2015 and held it in 15 quarters. The position peaked at $2.82M in Q4 2015. 193 funds tracked by Wall St. Rank hold RVNC as of Q4 2023.

  • Baird Financial Group reported no remaining Revance Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
  • Baird Financial Group sold 61,586 Revance Therapeutics, Inc. shares in Q4 2023, an estimated $706K.
  • Baird Financial Group first reported a position in Revance Therapeutics, Inc. in Q2 2015 and held it in 15 quarters.
  • Baird Financial Group's Revance Therapeutics, Inc. position peaked at $2.82M in Q4 2015.
  • 193 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2023.

Based on Baird Financial Group's 13F filing for Q4 2023, filed 14 Feb 2024.